FI941137A - 2-debensoyl-2-acyltaxolderivat och förfaranden för framställning av dessa - Google Patents

2-debensoyl-2-acyltaxolderivat och förfaranden för framställning av dessa Download PDF

Info

Publication number
FI941137A
FI941137A FI941137A FI941137A FI941137A FI 941137 A FI941137 A FI 941137A FI 941137 A FI941137 A FI 941137A FI 941137 A FI941137 A FI 941137A FI 941137 A FI941137 A FI 941137A
Authority
FI
Finland
Prior art keywords
acyltaxol
debenzoyl
derivatives
preparation
methods
Prior art date
Application number
FI941137A
Other languages
English (en)
Finnish (fi)
Other versions
FI941137A0 (sv
Inventor
David G K Kingston
Ashok Gopal Chaudhary
Milind Moreshwar Gharpure
John Matthew Rimoldi
A A Leslie Gunatilaka
Original Assignee
Virginia Tech Intell Prop
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Tech Intell Prop filed Critical Virginia Tech Intell Prop
Publication of FI941137A0 publication Critical patent/FI941137A0/sv
Publication of FI941137A publication Critical patent/FI941137A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
FI941137A 1993-03-11 1994-03-10 2-debensoyl-2-acyltaxolderivat och förfaranden för framställning av dessa FI941137A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2975993A 1993-03-11 1993-03-11
US3061293A 1993-03-11 1993-03-11

Publications (2)

Publication Number Publication Date
FI941137A0 FI941137A0 (sv) 1994-03-10
FI941137A true FI941137A (sv) 1994-09-12

Family

ID=26705310

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941137A FI941137A (sv) 1993-03-11 1994-03-10 2-debensoyl-2-acyltaxolderivat och förfaranden för framställning av dessa

Country Status (12)

Country Link
US (3) US5703247A (sv)
EP (1) EP0617034A1 (sv)
JP (1) JPH06329650A (sv)
KR (1) KR940021543A (sv)
CN (1) CN1108653A (sv)
AU (1) AU678423B2 (sv)
CA (1) CA2118867A1 (sv)
FI (1) FI941137A (sv)
HU (1) HUT69170A (sv)
IL (1) IL108873A0 (sv)
NO (1) NO940825L (sv)
NZ (1) NZ250998A (sv)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998656A (en) 1991-09-23 1999-12-07 Florida State University C10 tricyclic taxanes
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
US5710287A (en) * 1991-09-23 1998-01-20 Florida State University Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
US6018073A (en) * 1991-09-23 2000-01-25 Florida State University Tricyclic taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
US6339164B1 (en) 1993-01-29 2002-01-15 Florida State University C2 substituted phenyl taxane derivatives and pharmaceutical compositions containing them
GB9405400D0 (en) * 1994-03-18 1994-05-04 Erba Carlo Spa Taxane derivatives
EP0855909A4 (en) * 1995-09-13 2000-06-07 Univ Florida State TAXANES WITH RADIOSENSITIZING EFFECT AND THEIR PHARMACEUTICAL PREPARATIONS
CA2253513A1 (en) * 1996-05-06 1997-11-13 Florida State University 1-deoxy baccatin iii, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
US5773464A (en) * 1996-09-30 1998-06-30 Bristol-Myers Squibb Company C-10 epoxy taxanes
US5977386A (en) * 1996-12-24 1999-11-02 Bristol-Myers Squibb Company 6-thio-substituted paclitaxels
US5739359A (en) * 1997-01-24 1998-04-14 Virginia Tech Intellectual Properties, Inc. Methods for preparing 1-deoxy paclitaxels
US5902822A (en) * 1997-02-28 1999-05-11 Bristol-Myers Squibb Company 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
EP1019347B1 (en) 1997-08-21 2003-03-19 Florida State University Method for the synthesis of taxanes
US5917062A (en) * 1997-11-21 1999-06-29 Indena S.P.A Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
US6410757B1 (en) * 1999-02-16 2002-06-25 Bio Research Corporation Of Yokohama Baccatin derivatives and a process for producing the same
JP4502338B2 (ja) * 1999-09-17 2010-07-14 株式会社横浜国際バイオ研究所 タキソイド化合物の製造法
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AR030188A1 (es) * 2000-02-02 2003-08-13 Univ Florida State Res Found Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
WO2001056564A1 (en) * 2000-02-02 2001-08-09 Florida State University Research Foundation, Inc. C10 heterosubstituted acetate taxanes as antitumor agents
CN1362958A (zh) 2000-02-02 2002-08-07 佛罗里达州立大学研究基金有限公司 用作抗肿瘤剂的c7碳酸酯取代的紫杉烷
CZ20013519A3 (cs) 2000-02-02 2002-04-17 Florida State University Research Foundation, Inc. Taxany s C7 heterosubstituovaným acetátem jako protinádorové látky
RU2264400C2 (ru) 2000-02-02 2005-11-20 Флорида Стейт Юниверсити Рисерч Фаундейшн, Инк. Таксан, фармацевтическая композиция на его основе и способ ингибирования роста опухоли
US6649632B2 (en) * 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
US6452024B1 (en) 2000-02-22 2002-09-17 Chaichem Pharmaceuticals International Process for extraction and purification of paclitaxel from natural sources
US6624317B1 (en) 2000-09-25 2003-09-23 The University Of North Carolina At Chapel Hill Taxoid conjugates as antimitotic and antitumor agents
DK2314293T3 (en) 2001-01-16 2017-04-18 Vascular Therapies Llc IMPLANTABLE DEVICE CONTAINING RESORBABLE MATERIAL MATERIAL AND RAPAMYCINE FOR PREVENTION OR TREATMENT OF VASCULOPROLIFERATIVE DISEASES
CA2494074A1 (en) * 2002-08-02 2004-02-12 Immunogen, Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
US20080220074A1 (en) * 2002-10-04 2008-09-11 Elan Corporation Plc Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
US20040132991A1 (en) * 2002-10-09 2004-07-08 Phytogen Life Sciences Inc. Novel taxanes and methods related to use and preparation thereof
US6759539B1 (en) 2003-02-27 2004-07-06 Chaichem Pharmaceuticals International Process for isolation and purification of paclitaxel from natural sources
US7064980B2 (en) * 2003-09-17 2006-06-20 Sandisk Corporation Non-volatile memory and method with bit line coupled compensation
US7202370B2 (en) * 2003-10-27 2007-04-10 Conor Medsystems, Inc. Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
PE20050693A1 (es) * 2004-02-13 2005-09-27 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
TW200540164A (en) 2004-03-05 2005-12-16 Univ Florida State Res Found C7 lactyloxy-substituted taxanes
EP2091932B1 (en) * 2004-04-23 2013-12-11 Chatham Biotec Ltd. Semi-synthesis and isolation of taxane intermediates from a mixture of taxanes
US7893283B2 (en) * 2004-06-04 2011-02-22 Chatham Biotec, Limited Semi-synthesis of taxane intermediates and their conversion to paclitaxel and docetaxel
US20050288520A1 (en) 2004-06-25 2005-12-29 Phytogen Life Sciences Inc. One pot synthesis of taxane derivatives and their conversion to paclitaxel and docetaxel
US20050288521A1 (en) * 2004-06-29 2005-12-29 Phytogen Life Sciences Inc. Semi-synthetic conversion of paclitaxel to docetaxel
CA2486285C (en) * 2004-08-30 2017-03-07 Viktor S. Goldmakher Immunoconjugates targeting syndecan-1 expressing cells and use thereof
EP1688415A1 (en) * 2004-12-07 2006-08-09 Aventis Pharma S.A. Cytotoxic agents comprising new C-2 modified taxanes
EP1669358A1 (en) 2004-12-07 2006-06-14 Aventis Pharma S.A. Cytotoxic agents comprising new taxanes
MX2007009748A (es) * 2005-02-14 2007-09-26 Univ Florida State Res Found Composiciones de taxano sustituidas con esteres ciclopropilicos en c10.
US7358378B2 (en) 2005-06-10 2008-04-15 Florida State University Research Foundation, Inc. Processes for the preparation of paclitaxel
JP2008545791A (ja) 2005-06-10 2008-12-18 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 多環式縮合環化合物の製造法
BRPI0821417A2 (pt) * 2007-12-26 2015-06-16 Biotest Ag Método para diminuir a adesão de células de estroma a células tumorais que expressam cd138 em células tumorais de um indivíduo em necessidade do mesmo
WO2009080829A1 (en) * 2007-12-26 2009-07-02 Biotest Ag Agents targeting cd138 and uses thereof
AR069979A1 (es) * 2007-12-26 2010-03-03 Biotest Ag Metodo para disminuir los efectos secundarios citotoxicos y mejorar la eficacia de los inmunoconjugados
RU2547939C2 (ru) * 2007-12-26 2015-04-10 Биотест Аг Иммуноконъюгаты, направленные на cd138, и их применение
WO2009145981A1 (en) * 2008-03-31 2009-12-03 Florida State University Research Foundation, Inc. C(10) ethyl ester and c(10) cyclopropyl ester substituted taxanes
RU2632108C2 (ru) 2011-12-08 2017-10-02 Биотест Аг Применения иммуноконъюгатов, мишенью которых является cd138
CA3092037A1 (en) 2018-02-21 2019-08-29 Celgene Corporation Bcma-binding antibodies and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2601676B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Procede de preparation du taxol et du desacetyl-10 taxol
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5015744A (en) * 1989-11-14 1991-05-14 Florida State University Method for preparation of taxol using an oxazinone
FR2679230B1 (fr) * 1991-07-16 1993-11-19 Rhone Poulenc Rorer Sa Nouveaux derives d'analogues du taxol, leur preparation et les compositions qui les contiennent.
US5399726A (en) * 1993-01-29 1995-03-21 Florida State University Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups
DK0642503T3 (da) * 1991-09-23 2000-05-22 Bristol Myers Squibb Co 10-Desacetoxytaxolderivater
US5283253A (en) * 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
CA2130578A1 (en) * 1992-04-17 1993-10-28 Geewananda P. Gunawardana Taxol derivatives
WO1994005282A1 (en) * 1992-09-04 1994-03-17 The Scripps Research Institute Water soluble taxol derivatives
FR2697019B1 (fr) * 1992-10-15 1994-11-25 Rhone Poulenc Rorer Sa Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5356928A (en) * 1992-11-06 1994-10-18 Hauser Chemical Research, Inc. Cytotoxic agents

Also Published As

Publication number Publication date
US5703247A (en) 1997-12-30
HU9400710D0 (en) 1994-06-28
JPH06329650A (ja) 1994-11-29
NZ250998A (en) 1996-02-27
CA2118867A1 (en) 1994-09-12
US6002023A (en) 1999-12-14
IL108873A0 (en) 1994-06-24
NO940825D0 (no) 1994-03-09
HUT69170A (en) 1995-08-28
NO940825L (no) 1994-09-12
US5614645A (en) 1997-03-25
AU678423B2 (en) 1997-05-29
CN1108653A (zh) 1995-09-20
EP0617034A1 (en) 1994-09-28
FI941137A0 (sv) 1994-03-10
AU5647494A (en) 1994-09-15
KR940021543A (ko) 1994-10-19

Similar Documents

Publication Publication Date Title
FI941137A (sv) 2-debensoyl-2-acyltaxolderivat och förfaranden för framställning av dessa
FI961599A (sv) 1N-alkyl-N-arylpyrimidinaminer och derivat därav
FI953479A0 (sv) 1-arylpyrimidinderivat och farmaceutisk användning av dessa
CY2003003I1 (el) Παραγωγα πυριμιδινης και μεθοδος για την παρασκευη τους
DK0719278T3 (da) Androstenonderivat
EE03486B1 (et) Pürasool-4-üülbensoüüli derivaadid ja nende kasutamine herbitsiididena
DE59208263D1 (de) 3-Aryl-4-hydroxy-delta3-dihydrofuranon- und 3-Aryl-4-hydroxy-delta3-dihydrothiophenon-Derivate
FI953981A0 (sv) 2-Bensyl-polycykliska guaninderivat och förfarande för deras framställning
FI955051A0 (sv) Heterocykliska föreningar och framställning och användning av desamma
FI962445A0 (sv) Paroxetintabletter och förfarande för framställning av dem
FI944713A0 (sv) 4-difenylmetylpiperidinderivat och förfarande för deras framställning
FI942932A (sv) Farmaceutisk komposition och förfarande för dess framställning
FI940775A0 (sv) Förfarande för framställning av alfa-fenylisoserinderivat och användning av dem
FI953021A0 (sv) Derivat av 4-bensoylisoxazol och deras användning som herbicider
ITMI910080A1 (it) Derivati arilvinilamidici e procedimento per la loro preparazione
FI941914A (sv) 2-amino-4-kinolindihydropyridiner, förfaranden för framställning av dessa och användning av dessa
FI955679A0 (sv) Piperidinderivater, framställning och användning därav
FI955123A (sv) Komposition innehållande kolestyramin och förfarande för framställning av densamma
FI961977A (sv) N-substituerade azabicykloalkanderivat, deras framställning och användning
NO922934D0 (no) Cykloheksan- og tetrahydropyranderivater
FI940403A (sv) Ellipticinderivat och förfarande för dess framställning
FI944842A (sv) Fluorerade 4-aminoandrostadienonderivat och förfarande för deras framställning
EE03614B1 (et) Pürasool-4-üül-bensoüüli derivaadid ja nende kasutamine herbitsiididena
DE59407726D1 (de) 3-Aryl-4-hydroxy-3-dihydrofuranon-Derivate
FI950303A0 (sv) Pyridoindolobenzodiazepiner och derivat som antipsykotiska ämnen

Legal Events

Date Code Title Description
FD Application lapsed